Eli Lilly just gave investors several reasons to cheer.

The WisdomTree U.S. Quality Dividend Growth Index underwent its annual rebalance on December 11, 2024, refining its holdings ...

Goldman Sachs’ Asad Haider likes the prospects for medical technology companies, mid-cap biotechs, drug distributors.

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and ...

Lawsuits filed in New Jersey are part of hundreds of complaints against UnitedHealthcare, PBMs, and pharmaceutical giants ...

A British mum-of-two died suddenly at the age of 34 recently after allegedly falling violently ill following the consumption ...

By licensing a drug from Hansoh, Merck signaled that it isn’t prepared to fully challenge its rivals' dominance in the GLP-1 ...

Nonspecific anti-inflammatories like steroids might be entirely sidelined for mild-to-moderate chronic hand eczema now that three targeted topical agents are available.

Four drug manufacturers have announced plans to offer discounted drug prices to safety net providers under the federal 340B program via ...

Nestle is launching protein shots in the United States which it says help suppress appetite for people looking to shed pounds ...

The Richmond company (Nasdaq: BIOA) will get a fraction of the money upfront from Novartis (NYSE: NVS) — up to $20 million, ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...